DexCom (DXCM) Tops Q1 EPS by 9c; offers guidance

DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.56, $0.09 better than the analyst estimate of $0.47. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.17 billion.

GUIDANCE:

DexCom sees FY2026 revenue of $5.16-5.25 billion, versus the consensus of $5.226 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
• Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst